Posted in | News | Gold

Habanero Resources Identifies Altered Red Clay at Grand-Vallée North Prospect

Apex Geoscience has reported to Habanero Resources that the teams have finished the phase I sampling program at the Grande-Vallée north prospect, Quebec. The company identified altered red clay and has currently sent the samples to ALS Minerals Laboratory in Val d'Or for main element analysis.

Habanero’s President, Jason Gigliotti, commented that the company is expecting the results from the samples of this fresh prospect. The company is waiting for the samples from the Grand-Vallée north prospect and has pending results from Yukon’s Haldane Silver Prospect and the Lezai gold prospect, Quebec. It is expecting positive results from these prospects, which may ensure encouraging growth prospects for the company.

The company purchased the Grande-Vallée north aluminous clay prospect, which includes 5,574 adjacent acres in Quebec. This prospect is immediately bordering the north of the 6,441 ha Grande-Vallée property, which is an aluminous clay deposit that is situated 32 km to the northeast of Murdochville in Québec. The location of the property is across the St. Lawrence River and near numerous deepwater ports.

During 2011 November, drilling crews finished an initial geologic reconnaissance program at the Lezai gold prospect, Quebec. The company targeted five priority regions totally in the claims, depending on geologic collection work that shows potential gold and favourable geology. Crews sent 100 rock grab samples, including glacially transported boulders and outcrops, to ALS Minerals Laboratory for multi-element ICP-MS test and gold fire assays. The company identified mineralization, including quartz and silicification of veining mafic volcanic rock that has chalcopyrite and pyrite at two tested locations out of five.

The Lezai gold prospect has around 55,100 adjacent acres that are situated about 125 km to the northwest of Chibougamau in Quebec.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Habanero Resources Identifies Altered Red Clay at Grand-Vallée North Prospect. AZoMining. Retrieved on November 22, 2024 from https://www.azomining.com/News.aspx?newsID=5434.

  • MLA

    Scanlon, Joel. "Habanero Resources Identifies Altered Red Clay at Grand-Vallée North Prospect". AZoMining. 22 November 2024. <https://www.azomining.com/News.aspx?newsID=5434>.

  • Chicago

    Scanlon, Joel. "Habanero Resources Identifies Altered Red Clay at Grand-Vallée North Prospect". AZoMining. https://www.azomining.com/News.aspx?newsID=5434. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Habanero Resources Identifies Altered Red Clay at Grand-Vallée North Prospect. AZoMining, viewed 22 November 2024, https://www.azomining.com/News.aspx?newsID=5434.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.